“2017 was a milestone year for NuVasive as we surpassed the $1 billion revenue mark driven by impressive international sales growth of more than 20 percent, and achieved record profitability of 18.2 percent non-GAAP operating margins in the fourth quarter,” Gregory Lucier, chairman and chief executive of NuVasive, said in a statement.
NuVasive reported fourth quarter 2017 total revenue of $271.7 million, edging the $271.1 million reported for the fourth quarter 2016.
For the fourth quarter 2017, gross profit on a GAAP (Generally Accepted Accounting Principles) basis was $196.3 million and net income was reported at $24 million, or 46 cents per share.
RELATED: Dayton-area medical tech company to begin hiring for new location
That compares to net income of $6.4 million, or 11 cents per share, for the fourth quarter 2016.
Gross profit for the full-year 2017 was $760.5 million, besting gross profit of $722 last year.
The company reported net income on the year of $83 million, or $1.50 per share, for the full year 2017 compared to net income of $37.1 million, or 69 cents per share, for the full year 2016.